MetaCap

Who Owns Cabaletta Bio Stock?

NASDAQ: CABAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.9361-0.0739 (-7.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
86.32%
Institutional holders
206
  • Institutions 86.3%
  • Insiders 1.0%
  • Public and other 12.6%

Who owns Cabaletta Bio stock?

Institutional investors own about 86.3% of Cabaletta Bio's shares, spread across 206 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 1.04% of CABA.

The largest institutional holders are Jennison Associates LLC (9.29%), T. Rowe Price Investment Management, Inc. (8.75%) and Bain Capital Life Sciences Investors, LLC (7.99%). Together, the top 10 institutions control 48.7% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their CABA positions and 1 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CABA

Cabaletta Bio top institutional holders
InstitutionShares% HeldChange
Jennison Associates LLC20.03M9.29%+123.3%
T. Rowe Price Investment Management, Inc.18.87M8.75%+70.3%
Bain Capital Life Sciences Investors, LLC17.24M7.99%+78.2%
Blackrock Inc.10.75M4.99%+353.2%
Adage Capital Partners GP L.L.C.9.17M4.25%+3.9%
State Street Corporation8.05M3.73%+2.7%
Vanguard Capital Management LLC7.23M3.35%+79.4%
Cormorant Asset Management, LP5.00M2.32%-9.1%
Price (T.Rowe) Associates Inc4.42M2.05%+899.1%
Geode Capital Management, LLC4.28M1.98%+23.6%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CABA

Cabaletta Bio top fund holders
FundShares% Held
T. Rowe Price Small-Cap Value Fund, Inc.7.87M3.65%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund5.22M2.42%
TR PRICE-Price (T.Rowe) U.S. Small-Cap Value Equity Trust5.17M2.40%
Prudential Sector Funds, Inc.-PGIM Jennison Health Sciences Fund4.96M2.30%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF4.94M2.29%
iShares Trust-iShares Russell 2000 ETF4.22M1.96%
Prudential Jennison Small Co Fd., Inc.-PGIM JENNISON SMALL COMPANY Fd.2.70M1.25%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.88M0.87%
T. Rowe Price Health Sciences Fund, Inc.1.80M0.83%
T. Rowe Price Small-Cap Stock Fund, Inc.1.39M0.64%

Frequently asked questions

Who is the largest shareholder of Cabaletta Bio?

Jennison Associates LLC is the largest institutional shareholder of CABA, owning 9.29% of shares outstanding (20.03M shares) as of its latest 13F filing.

What percentage of Cabaletta Bio is owned by institutions?

Institutions own about 86.3% of CABA shares and 87.2% of the public float.

How much of Cabaletta Bio do insiders own?

Insiders, such as officers and directors, own about 1.04% of CABA shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related